Literature DB >> 18776302

Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: implications in transcription.

Luigi Xodo1, Manikandan Paramasivam, Alexandro Membrino, Susanna Cogoi.   

Abstract

The promoter of the KRAS proto-oncogene contains a critical nuclease hypersensitive element (NHE) forming G-quadruplex structures that are recognized by nuclear proteins: PARP-1, Ku70 and hnRNPA1. Here we have studied the interaction between hnRNPA1 (and its derivative UP1) and the G-quadruplexes of KRAS by EMSA, FRET and CD experiments. FRET and CD showed that hnRNPA1/UP1 is able to unfold the G-quadruplexes of KRAS and facilitate the quadruplex to duplex transformation. This finding strengthens our previous hypothesis that the transcription regulation of KRAS is mediated by G-quadruplex structures. Against this background we designed G4-decoy oligonucleotides specific for KRAS that exhibit a strong antiproliferative effect in pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776302     DOI: 10.1093/nass/nrn081

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser (Oxf)        ISSN: 0261-3166


  10 in total

1.  Parp3 promotes long-range end joining in murine cells.

Authors:  Jacob V Layer; J Patrick Cleary; Alexander J Brown; Kristen E Stevenson; Sara N Morrow; Alexandria Van Scoyk; Rafael B Blasco; Elif Karaca; Fei-Long Meng; Richard L Frock; Trevor Tivey; Sunhee Kim; Hailey Fuchs; Roberto Chiarle; Frederick W Alt; Steven A Roberts; David M Weinstock; Tovah A Day
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

2.  High-resolution three-dimensional NMR structure of the KRAS proto-oncogene promoter reveals key features of a G-quadruplex involved in transcriptional regulation.

Authors:  Abdelaziz Kerkour; Julien Marquevielle; Stefaniia Ivashchenko; Liliya A Yatsunyk; Jean-Louis Mergny; Gilmar F Salgado
Journal:  J Biol Chem       Date:  2017-03-22       Impact factor: 5.157

3.  LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes.

Authors:  Prerna Dabral; Jay Babu; Andrew Zareie; Subhash C Verma
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

Review 4.  G4-quadruplex-binding proteins: review and insights into selectivity.

Authors:  Vanessa Meier-Stephenson
Journal:  Biophys Rev       Date:  2022-04-20

Review 5.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

6.  A Quantitative Proteomic Approach for the Identification of DNA Guanine Quadruplex-Binding Proteins.

Authors:  Zi Gao; Preston Williams; Lin Li; Yinsheng Wang
Journal:  J Proteome Res       Date:  2021-09-27       Impact factor: 4.466

Review 7.  The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective.

Authors:  Claudia Sissi; Barbara Gatto; Manlio Palumbo
Journal:  Biochimie       Date:  2011-04-29       Impact factor: 4.079

8.  Promoter-Dependent Translation Controlled by p54nrb and hnRNPM during Myoblast Differentiation.

Authors:  Nadera Ainaoui; Fransky Hantelys; Edith Renaud-Gabardos; Morgane Bunel; Frédéric Lopez; Françoise Pujol; Remi Planes; Elmostafa Bahraoui; Carole Pichereaux; Odile Burlet-Schiltz; Angelo Parini; Barbara Garmy-Susini; Anne-Catherine Prats
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

9.  Relevance of G-quadruplex structures to pharmacogenetics.

Authors:  Simone L Cree; Martin A Kennedy
Journal:  Front Pharmacol       Date:  2014-07-08       Impact factor: 5.810

10.  SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.

Authors:  Yuki Kuranaga; Nobuhiko Sugito; Haruka Shinohara; Takuya Tsujino; Kohei Taniguchi; Kazumasa Komura; Yuko Ito; Tomoyoshi Soga; Yukihiro Akao
Journal:  Int J Mol Sci       Date:  2018-10-02       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.